• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即时检测恒温核酸扩增检测:无提取样品采集和准备的进展和瓶颈。

Point-of-care isothermal nucleic acid amplification tests: progress and bottlenecks for extraction-free sample collection and preparation.

机构信息

Department of Bioengineering, Rice University, Houston, TX, USA.

Rice360 Institute for Global Health Technologies, Rice University, Houston, TX, USA.

出版信息

Expert Rev Mol Diagn. 2024 Jun;24(6):509-524. doi: 10.1080/14737159.2024.2375233. Epub 2024 Jul 8.

DOI:10.1080/14737159.2024.2375233
PMID:38973430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11514575/
Abstract

INTRODUCTION

Suitable sample collection and preparation methods are essential to enable nucleic acid amplification testing at the point of care (POC). Strategies that allow direct isothermal nucleic acid amplification testing (iNAAT) of crude sample lysate without the need for nucleic acid extraction minimize time to result as well as the need for operator expertise and costly infrastructure.

AREAS COVERED

The authors review research to understand how sample matrix and preparation affect the design and performance of POC iNAATs. They focus on approaches where samples are directly combined with liquid reagents for preparation and amplification via iNAAT strategies. They review factors related to the type and method of sample collection, storage buffers, and lysis strategies. Finally, they discuss RNA targets and relevant regulatory considerations.

EXPERT OPINION

Limitations in sample preparation methods are a significant technical barrier preventing implementation of nucleic acid testing at the POC. The authors propose a framework for co-designing sample preparation and amplification steps for optimal performance with an extraction-free paradigm by considering a sample matrix and lytic strategy prior to an amplification assay and readout. In the next 5 years, the authors anticipate increasing priority on the co-design of sample preparation and iNAATs.

摘要

简介

在现场即时检测(POC)中,合适的样本采集和准备方法对于核酸扩增检测至关重要。能够直接对未经核酸提取的原始样本裂解液进行等温核酸扩增检测(iNAAT)的策略,可以最大限度地减少检测结果所需的时间,减少对操作人员专业知识和昂贵基础设施的需求。

涵盖领域

作者回顾了相关研究,以了解样本基质和制备如何影响 POC iNAAT 的设计和性能。他们重点介绍了通过 iNAAT 策略,直接将样本与液体试剂混合进行制备和扩增的方法。他们回顾了与样本采集类型和方法、储存缓冲液和裂解策略相关的因素。最后,他们讨论了 RNA 靶标和相关的监管考虑因素。

专家意见

样本制备方法的局限性是阻碍核酸检测在 POC 实现的重大技术障碍。作者提出了一个框架,通过在扩增检测和读取之前,考虑样本基质和裂解策略,以无提取的范式,共同设计样本制备和扩增步骤,以实现最佳性能。在未来 5 年内,作者预计将优先考虑共同设计样本制备和 iNAAT。

相似文献

1
Point-of-care isothermal nucleic acid amplification tests: progress and bottlenecks for extraction-free sample collection and preparation.即时检测恒温核酸扩增检测:无提取样品采集和准备的进展和瓶颈。
Expert Rev Mol Diagn. 2024 Jun;24(6):509-524. doi: 10.1080/14737159.2024.2375233. Epub 2024 Jul 8.
2
Low-complexity manual nucleic acid amplification tests for pulmonary tuberculosis in children.用于儿童肺结核的低复杂度手动核酸扩增检测
Cochrane Database Syst Rev. 2025 Jun 25;6(6):CD015806. doi: 10.1002/14651858.CD015806.pub2.
3
Diagnosis of visceral and cutaneous leishmaniasis using loop-mediated isothermal amplification (LAMP) protocols: a systematic review and meta-analysis.应用环介导等温扩增(LAMP)技术诊断内脏利什曼病和皮肤利什曼病:一项系统评价和荟萃分析。
Parasit Vectors. 2022 Jan 24;15(1):34. doi: 10.1186/s13071-021-05133-2.
4
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
5
Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.用于诊断 18 个月及以下婴儿和儿童 HIV-1 或 HIV-2 感染的即时检测 HIV 核酸检测。
Cochrane Database Syst Rev. 2021 Aug 12;8(8):CD013207. doi: 10.1002/14651858.CD013207.pub2.
6
Parallel use of low-complexity automated nucleic acid amplification tests on respiratory and stool samples with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children.在有或没有侧向流动脂阿拉伯甘露聚糖检测的情况下,对呼吸道和粪便样本并行使用低复杂度自动核酸扩增检测以检测儿童肺结核病。
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD016071. doi: 10.1002/14651858.CD016071.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Room temperature storage and shipping of encapsulated synthetic RNAs as quality control materials for SARS-CoV-2 molecular diagnostic assays.作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)分子诊断检测的质量控制材料,对封装的合成RNA进行室温储存和运输。
J Virol Methods. 2025 Sep;337:115169. doi: 10.1016/j.jviromet.2025.115169. Epub 2025 Apr 25.
9
Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa.用于从鼻咽拭子或未经处理的唾液中检测新型冠状病毒的比色逆转录环介导等温扩增技术:一项在非洲开展的多国诊断准确性研究
Lancet Glob Health. 2025 Jul;13(7):e1258-e1267. doi: 10.1016/S2214-109X(25)00150-0.
10
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.

引用本文的文献

1
Integrated microfluidic cartridge for rapid and colorimetric detection of Mycoplasma pneumoniae.用于快速比色检测肺炎支原体的集成微流控芯片
Mikrochim Acta. 2025 Aug 6;192(9):559. doi: 10.1007/s00604-025-07377-6.
2
Structural basis for intrinsic strand displacement activity of mitochondrial DNA polymerase.线粒体DNA聚合酶内在链置换活性的结构基础。
Nat Commun. 2025 Mar 11;16(1):2417. doi: 10.1038/s41467-025-57594-z.

本文引用的文献

1
Large-volume RT-LAMP enables extraction-free amplification of HIV RNA from fingerstick plasma.大体积 RT-LAMP 可从指尖血浆中提取游离的 HIV RNA 进行扩增。
Anal Chim Acta. 2024 Jun 8;1307:342560. doi: 10.1016/j.aca.2024.342560. Epub 2024 Apr 1.
2
Advances in Simple, Rapid, and Contamination-Free Instantaneous Nucleic Acid Devices for Pathogen Detection.用于病原体检测的简单、快速且无污染的即时核酸装置的进展。
Biosensors (Basel). 2023 Jul 14;13(7):732. doi: 10.3390/bios13070732.
3
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
一种用于资源有限环境中检测 HPV16 和 HPV18 DNA 的集成等温核酸扩增检测方法。
Sci Transl Med. 2023 Jun 21;15(701):eabn4768. doi: 10.1126/scitranslmed.abn4768.
4
Detection of viral RNAs at ambient temperature via reporter proteins produced through the target-splinted ligation of DNA probes.通过目标物夹置 DNA 探针的连接产生报告蛋白,在环境温度下检测病毒 RNA。
Nat Biomed Eng. 2023 Dec;7(12):1571-1582. doi: 10.1038/s41551-023-01028-y. Epub 2023 May 4.
5
Disposable platform for bacterial lysis and nucleic acid amplification based on a single USB-powered printed circuit board.基于单个 USB 供电印刷电路板的细菌裂解和核酸扩增用一次性平台。
PLoS One. 2023 Apr 26;18(4):e0284424. doi: 10.1371/journal.pone.0284424. eCollection 2023.
6
Development of a hybridization chain reaction-powered lab-on-fiber device for ultrafast point-of-care testing of circulating tuor DNA in whole blood.用于全血中循环肿瘤DNA超快速即时检测的杂交链式反应驱动的光纤上实验室装置的开发。
Talanta. 2023 Jul 1;259:124475. doi: 10.1016/j.talanta.2023.124475. Epub 2023 Mar 28.
7
SARS-CoV-2 pathogenesis.严重急性呼吸综合征冠状病毒 2 型的发病机制。
Nat Rev Microbiol. 2022 May;20(5):270-284. doi: 10.1038/s41579-022-00713-0. Epub 2022 Mar 30.
8
Evaluation of saliva self-collection devices for SARS-CoV-2 diagnostics.唾液自我采集装置用于 SARS-CoV-2 诊断的评估。
BMC Infect Dis. 2022 Mar 25;22(1):284. doi: 10.1186/s12879-022-07285-7.
9
Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example.核酸扩增技术(NAATs)的进展:以新冠病毒即时检测诊断为例
Biosens Bioelectron. 2022 Jun 15;206:114109. doi: 10.1016/j.bios.2022.114109. Epub 2022 Feb 26.
10
Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.用于分子、血清学或疫苗开发目的的高致病性病毒灭活方法。
Pathogens. 2022 Feb 19;11(2):271. doi: 10.3390/pathogens11020271.